Skip to main content
. 2014 Apr 30;2014:570241. doi: 10.1155/2014/570241

Table 4.

Cardiac oxidative/nitrosative stress and inflammation according to iron diet, DOX treatment, and supplementation with FCM.

Group
1 2 3 4 5 6 7 8
Parameter
 MDA (nmol/mg protein) 3.6 ± 0.2** 3.5 ± 0.3** 2.9 ± 0.1†† 2.7 ± 0.2* 4.3 ± 0.2‡‡ 2.5 ± 0.2§§ 1.8 ± 0.2|| 5.7 ± 0.3
 Cu,Zn-SOD (U/mg protein) 36.9 ± 3.2** 34.9 ± 2.0** 30.4 ± 2.1†† 27.3 ± 3.0* 42.3 ± 2.4‡‡ 26.3 ± 2.1§§ 16.0 ± 1.8|| 49.2 ± 3.3
 GPx (U/mg protein) 409 ± 24** 399 ± 20‡‡ 360 ± 20†† 353 ± 23* 459 ± 24‡‡ 320 ± 24§§ 256 ± 21|| 507 ± 32
 GSH : GSSG ratio 2.5 ± 0.2** 2.6 ± 0.1** 3.6 ± 0.2†† 3.8 ± 0.2* 2.4 ± 0.2‡‡ 3.9 ± 0.1§§ 4.8 ± 0.2|| 2.0 ± 0.2
 Nitrotyrosine (%/area) 18.0 ± 3.3 17.1 ± 2.6 16.9 ± 3.1 16.1 ± 2.2* 29.1 ± 3.4 16.8 ± 3.8 11.6 ± 1.3 34.5 ± 4.5
 iNOS (%/area) 6.9 ± 1.0 6.4 ± 1.1 6.7 ± 0.8 6.5 ± 0.9 21.4 ± 1.7 2.5 ± 0.4 2.3 ± 0.6 20.3 ± 2.0
 TNF-α (%/area) 15.1 ± 1.4 14.4 ± 1.5 14.2 ± 1.2 14.1 ± 1.3 19.6 ± 1.4 15.0 ± 1.5 11.9 ± 1.1§ 23.6 ± 2.0§
 IL-6 (%/area) 15.7 ± 2.2 14.6 ± 1.7 15.2 ± 1.4 14.4 ± 1.6 28.4 ± 2.5 20.3 ± 1.6 3.6 ± 1.0§ 34.9 ± 3.1§
 Collagen III (%/area) 7.4 ± 1.0 7.5 ± 0.9 7.3 ± 1.1 6.6 ± 0.9 13.0 ± 1.5 7.0 ± 1.1 4.3 ± 0.7§ 13.9 ± 1.9

Data presented as mean ± SD. A brief tabular overview of treatments in Groups 1–8 is included in Table 2. Further details are described in the Materials and Methods section. MDA: malondialdehyde; Cu,Zn-SOD: copper-zinc superoxide dismutase; GPx: glutathione peroxidase; GSH : GSSG: reduced glutathione : oxidised glutathione; iNOS: inducible nitric oxide synthase; TNF-α: tumour necrosis factor-alpha; IL-6: interleukin-6.

*P < 0.01 versus G5, G7, and G8; P < 0.01 versus G1, G2, G3, and G4; P < 0.01 versus G1, G2, G3, G4, G6, and G7; § P < 0.01 versus all groups; || P < 0.01 versus G8; P < 0.01 versus G1, G2, G3, G4, and G6; **P < 0.01 versus G3 to G8; †† P < 0.01 versus G5 to G8; ‡‡ P < 0.01 versus G6 to G8; §§ P < 0.01 versus G7, G8.